Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of Illinois at Chicago
With
Sanofi
The primary objective of this descriptive study is to determine and compare the plasma, epithelial lining fluid (ELF), and alveolar macrophage (AM) concentrations following multiple oral doses of telithromycin and azithromycin in healthy, non-smoking adult subjects.
Age
18–55
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Between 18 and 55 years, inclusive, of age
No history of smoking within the last 1 year
Body weight within +/- 15% of the Metropolitan Life Insurance Company tables
No clinically important abnormalities in the medical history or physical exam
Female subjects of childbearing potential must have a negative pregnancy test
Female subjects of childbearing potential must use reliable methods of birth control
You may not be if
Allergy to telithromycin, azithromycin, or any macrolide antibiotic
Allergy or serious adverse reactions to benzodiazepines or lidocaine
History of renal, gastrointestinal, or liver disease
Significant hypertension
Clinically significant heart or pulmonary diseases
History of drug or alcohol dependence within 12 months of study entry
Positive pregnancy test
Currently breast feeding
Use of any drug within 2 weeks of study entry
Received an investigational drug within 30 days of study entry
Clareo Health | Intrapulmonary Pharmacokinetics of Antibiotics
